AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haider, M. A.
Right arrow Articles by Trachtenberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haider, M. A.
Right arrow Articles by Trachtenberg, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2211
AJR 2007; 189:323-328
© American Roentgen Ray Society


Original Research

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

Masoom A. Haider1, Theodorus H. van der Kwast2,3, Jeff Tanguay2, Andrew J. Evans2, Ali-Tahir Hashmi1, Gina Lockwood4 and John Trachtenberg5

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network and Mount Sinai Hospital, University of Toronto, 610 University Ave., Toronto, ON M5G 2M9, Canada.
2 Department of Pathology and Laboratory Medicine, Princess Margaret Hospital, University Health Network, University of Toronto, ON, Canada.
3 Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, ON, Canada.
4 Department of Biostatistics, Princess Margaret Hospital, University Health Network, University of Toronto, ON, Canada.
5 Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, ON, Canada.

OBJECTIVE. The objective of our study was to compare T2-weighted MRI alone and T2 combined with diffusion-weighted imaging (DWI) for the localization of prostate cancer.

SUBJECTS AND METHODS. T2-weighted imaging and DWI (b value = 600 s/mm2) were performed in 49 patients before radical prostatectomy using an endorectal coil at 1.5 T in this prospective trial. The peripheral zone of the prostate was divided into sextants and the transition zone into left and right halves. T2 images alone and then T2 images combined with apparent diffusion coefficient (ADC) maps (T2 + DWI) were scored for the likelihood of tumor and were compared with whole-mount histology results. Fixed window and level settings were used to display the ADC maps. Only tumors with an area of more than 0.13 cm2 (> 4 mm diameter) and a Gleason score of ≥ 6 were considered significant. The area under the receiver operating characteristic curve (Az) was used to assess accuracy.

RESULTS. In the peripheral zone, the Az value was significantly higher (p = 0.004) for T2 plus DWI (Az = 0.89) than for T2 imaging alone (Az = 0.81). Performance was poorer in the transition zone for both T2 plus DWI (Az = 0.78) and T2 (Az = 0.79). For the whole prostate, sensitivity was significantly higher (p < 0.001) with T2 plus DWI (81% [120/149]) than with T2 imaging alone (54% [81/149]), with T2 plus DWI showing only a slight loss in specificity compared with T2 imaging alone (84% [204/243] vs 91% [222/243], respectively).

CONCLUSION. Combined T2 and DWI MRI is better than T2 imaging alone in the detection of significant cancer (Gleason score ≥ 6 and diameter > 4 mm) within the peripheral zone of the prostate.

Keywords: diffusion-weighted imaging • MRI technique • oncologic imaging • prostate cancer • radiologic-pathologic correlation • T2-weighted imaging


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
W. Luboldt, R. Kufer, N. Blumstein, T. L. Toussaint, A. Kluge, M. D. Seemann, and H.-J. Luboldt
Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and 11C-Choline PET/CT for Detection of Bone Metastases
Radiology, October 10, 2008; (2008) 2492080038.
[Abstract] [Full Text]


Home page
RadiologyHome page
C. K. Kuhl, F. Traber, J. Gieseke, W. Drahanowsky, N. Morakkabati-Spitz, W. Willinek, M. von Falkenhausen, C. Manka, and H. H. Schild
Whole-Body High-Field-Strength (3.0-T) MR Imaging in Clinical Practice * Part II. Technical Considerations and Clinical Applications
Radiology, April 1, 2008; 247(1): 16 - 35.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.